I am pleased to share that my first postdoc paper from the @halllab.bsky.social is now on bioRxiv! 🎉
We used long-read #metagenomics to explore how the gut microbiome and #antimicrobialresistance landscape shift across advanced chronic #liverdisease (ACLD)
www.biorxiv.org/content/10.6...
We used long-read #metagenomics to explore how the gut microbiome and #antimicrobialresistance landscape shift across advanced chronic #liverdisease (ACLD)
www.biorxiv.org/content/10.6...
Decoding the microbiome and resistome of advanced chronic liver disease through long-read metagenomics
Introduction - Patients with advanced chronic liver disease (ACLD) and underlying cirrhosis frequently require repeated courses of antimicrobial therapy, with both the frequency and spectrum of antimi...
www.biorxiv.org
December 10, 2025 at 12:09 PM
I am pleased to share that my first postdoc paper from the @halllab.bsky.social is now on bioRxiv! 🎉
We used long-read #metagenomics to explore how the gut microbiome and #antimicrobialresistance landscape shift across advanced chronic #liverdisease (ACLD)
www.biorxiv.org/content/10.6...
We used long-read #metagenomics to explore how the gut microbiome and #antimicrobialresistance landscape shift across advanced chronic #liverdisease (ACLD)
www.biorxiv.org/content/10.6...
New online! Preventing the progression of cirrhosis to decompensation and death
Preventing the progression of cirrhosis to decompensation and death
Nature Reviews Gastroenterology & Hepatology, Published online: 27 January 2025; doi:10.1038/s41575-024-01031-xThis Review describes the progression of advanced chronic liver disease (ACLD) from its early stages (compensated ACLD) to more advanced disease…
go.nature.com
January 27, 2025 at 6:48 PM
New online! Preventing the progression of cirrhosis to decompensation and death
ICYMI: New online! Preventing the progression of cirrhosis to decompensation and death
Preventing the progression of cirrhosis to decompensation and death
Nature Reviews Gastroenterology & Hepatology, Published online: 27 January 2025; doi:10.1038/s41575-024-01031-xThis Review describes the progression of advanced chronic liver disease (ACLD) from its early stages (compensated ACLD) to more advanced disease…
go.nature.com
January 28, 2025 at 6:49 PM
ICYMI: New online! Preventing the progression of cirrhosis to decompensation and death
ICYMI: New online! Preventing the progression of cirrhosis to decompensation and death
Preventing the progression of cirrhosis to decompensation and death
Nature Reviews Gastroenterology & Hepatology, Published online: 27 January 2025; doi:10.1038/s41575-024-01031-xThis Review describes the progression of advanced chronic liver disease (ACLD) from its early stages (compensated ACLD) to more advanced disease…
www.nature.com
February 2, 2025 at 6:50 PM
ICYMI: New online! Preventing the progression of cirrhosis to decompensation and death
My mother fought for special education since early 1960s. She’s one of the founders of ACLD — association for children with learning disabilities.
Never known for my silence. Don’t care if I’m put on mute! Silence is Complicity. Trump FIRED the ENTIRE Staff in the USED Office for Special Ed Programs! No Accountability means 7 Million Students will Suffer More! PLEASE FIND YOUR VOICES (202) 224-3121 youtu.be/L-JQ1q-13Ek?... go.bsky.app/SE6AQHv
October 13, 2025 at 12:24 AM
My mother fought for special education since early 1960s. She’s one of the founders of ACLD — association for children with learning disabilities.
might microd0se acld today and have either a breakdown or a breakthrough
February 28, 2025 at 4:02 PM
might microd0se acld today and have either a breakdown or a breakthrough
Anti-semitic terrorist supporter Mehdi Ha(ma)san is being dragged, so a reminder of when he got publicly called out on his Jew hatred:
www.youtube.com/watch?v=acLd...
www.youtube.com/watch?v=acLd...
Lawyer DISMANTLES Mehdi Hasan Anti-Israel LIES 🔥
YouTube video by J-TV: The Global Jewish Channel
www.youtube.com
October 25, 2025 at 9:51 PM
Anti-semitic terrorist supporter Mehdi Ha(ma)san is being dragged, so a reminder of when he got publicly called out on his Jew hatred:
www.youtube.com/watch?v=acLd...
www.youtube.com/watch?v=acLd...
@halllab.bsky.social
@matthewjdalby.bsky.social @raymondkiu.bsky.social @drvishalcpatel.bsky.social @richardmleggett.bsky.social @drmeriannem.bsky.social
www.biorxiv.org/content/10.6...
@matthewjdalby.bsky.social @raymondkiu.bsky.social @drvishalcpatel.bsky.social @richardmleggett.bsky.social @drmeriannem.bsky.social
www.biorxiv.org/content/10.6...
Decoding the microbiome and resistome of advanced chronic liver disease through long-read metagenomics
Introduction - Patients with advanced chronic liver disease (ACLD) and underlying cirrhosis frequently require repeated courses of antimicrobial therapy, with both the frequency and spectrum of antimi...
www.biorxiv.org
December 10, 2025 at 12:26 PM
Proud to present our group's work on utilizing deeplearning🤖🧠 to predict portal hypertension from liver biopsies🔬 in patients with ACLD!
www.journal-of-hepatology.eu/article/S016...
@reibergerthomas.bsky.social
Thanks to Team @jnkt.bsky.social for the support!
#AI #liver #hepatology
www.journal-of-hepatology.eu/article/S016...
@reibergerthomas.bsky.social
Thanks to Team @jnkt.bsky.social for the support!
#AI #liver #hepatology
May 13, 2025 at 6:08 PM
Proud to present our group's work on utilizing deeplearning🤖🧠 to predict portal hypertension from liver biopsies🔬 in patients with ACLD!
www.journal-of-hepatology.eu/article/S016...
@reibergerthomas.bsky.social
Thanks to Team @jnkt.bsky.social for the support!
#AI #liver #hepatology
www.journal-of-hepatology.eu/article/S016...
@reibergerthomas.bsky.social
Thanks to Team @jnkt.bsky.social for the support!
#AI #liver #hepatology
Drs. @LukasHARTL and @MarleneHINTERSTEININGER of @meduniwien.ac.at showed in @CGH @AGA that
adding the #Vasopressin #ADH Biomarker #Copeptin to the MELD score improves prognostication of patients with #cirrhosis #ACLD
📖 the full study 🔗 t.ly/11GOg
@easlnews.bsky.social @bavenocoop.bsky.social
adding the #Vasopressin #ADH Biomarker #Copeptin to the MELD score improves prognostication of patients with #cirrhosis #ACLD
📖 the full study 🔗 t.ly/11GOg
@easlnews.bsky.social @bavenocoop.bsky.social
July 6, 2025 at 8:05 AM
Drs. @LukasHARTL and @MarleneHINTERSTEININGER of @meduniwien.ac.at showed in @CGH @AGA that
adding the #Vasopressin #ADH Biomarker #Copeptin to the MELD score improves prognostication of patients with #cirrhosis #ACLD
📖 the full study 🔗 t.ly/11GOg
@easlnews.bsky.social @bavenocoop.bsky.social
adding the #Vasopressin #ADH Biomarker #Copeptin to the MELD score improves prognostication of patients with #cirrhosis #ACLD
📖 the full study 🔗 t.ly/11GOg
@easlnews.bsky.social @bavenocoop.bsky.social
July is Disability Pride Month. This annual celebration of differing abilities connects back to the passing of the Americans with Disabilities Act (ADA). It's on us all to celebrate our differences and make society inclusive and accessible for all. #LWV #ACLD
www.ameridisability.com/heres-what-t...
www.ameridisability.com/heres-what-t...
July 6, 2025 at 12:20 AM
July is Disability Pride Month. This annual celebration of differing abilities connects back to the passing of the Americans with Disabilities Act (ADA). It's on us all to celebrate our differences and make society inclusive and accessible for all. #LWV #ACLD
www.ameridisability.com/heres-what-t...
www.ameridisability.com/heres-what-t...
😲 Prêts à tenter votre chance ? ➡️ https://l.actu.fr/aCLd
September 23, 2025 at 10:58 AM
😲 Prêts à tenter votre chance ? ➡️ https://l.actu.fr/aCLd
Our work showed the value of long-read metagenomics for culture-independent taxonomic profiling of the gut microbiome and resistome in high-risk patients with ACLD.
Thanks to the Hall lab and co-authors for their support and guidance for this project
I hope you enjoy reading the preprint! 🤩🥼🧬
Thanks to the Hall lab and co-authors for their support and guidance for this project
I hope you enjoy reading the preprint! 🤩🥼🧬
December 10, 2025 at 12:23 PM
Our work showed the value of long-read metagenomics for culture-independent taxonomic profiling of the gut microbiome and resistome in high-risk patients with ACLD.
Thanks to the Hall lab and co-authors for their support and guidance for this project
I hope you enjoy reading the preprint! 🤩🥼🧬
Thanks to the Hall lab and co-authors for their support and guidance for this project
I hope you enjoy reading the preprint! 🤩🥼🧬
Smoking is observed to increase inflammation, fibrogenesis, and angiogenesis, as well as risk for extrahepatic malignancies in advanced chronic liver disease (ACLD) (Liver International journal).
40% of patients with ACLD have a history of smoking.
40% of patients with ACLD have a history of smoking.
September 29, 2025 at 6:35 PM
Smoking is observed to increase inflammation, fibrogenesis, and angiogenesis, as well as risk for extrahepatic malignancies in advanced chronic liver disease (ACLD) (Liver International journal).
40% of patients with ACLD have a history of smoking.
40% of patients with ACLD have a history of smoking.
Oral bacteria were found to colonize the gut in advanced chronic liver disease, coinciding with intestinal barrier damage and worsening liver health, suggesting new diagnostic and therapeutic approaches. doi.org/hbj5s5
Altered microbiome: Oral bacteria play a role in chronic liver disease, study reveals
Each year, more than two million people die from advanced chronic liver disease (ACLD). Previous research has linked gut microbiome disruptions to this condition and suggested that bacteria typically found in the mouth may colonize the gut.
medicalxpress.com
January 15, 2026 at 9:23 PM
Oral bacteria were found to colonize the gut in advanced chronic liver disease, coinciding with intestinal barrier damage and worsening liver health, suggesting new diagnostic and therapeutic approaches. doi.org/hbj5s5
After a long summer break, we continue introducing our work packages of project MOTION.
UP next is WP5 introduced and led by
@mathiasjachs.bsky.social
🖐️
Developing prognostic #NIT models for #ACLD or #PSVD
📷More info in the video below 📷
UP next is WP5 introduced and led by
@mathiasjachs.bsky.social
🖐️
Developing prognostic #NIT models for #ACLD or #PSVD
📷More info in the video below 📷
September 26, 2025 at 6:24 AM
After a long summer break, we continue introducing our work packages of project MOTION.
UP next is WP5 introduced and led by
@mathiasjachs.bsky.social
🖐️
Developing prognostic #NIT models for #ACLD or #PSVD
📷More info in the video below 📷
UP next is WP5 introduced and led by
@mathiasjachs.bsky.social
🖐️
Developing prognostic #NIT models for #ACLD or #PSVD
📷More info in the video below 📷
I apparently have high uric acid and I’m looking up info on foods that can help and stumbled onto this amazing chart
July 14, 2025 at 8:56 AM
I apparently have high uric acid and I’m looking up info on foods that can help and stumbled onto this amazing chart
Identification of a lipid signature associated with regression of ACLD with taurocholic and taurochenodeoxycholic
acid emerging as key predictors. @docberza.bsky.social tiny.cc/jp12001
acid emerging as key predictors. @docberza.bsky.social tiny.cc/jp12001
Metabolic phenotyping of patients with advanced chronic liver disease for better characterization of cirrhosis regression - PubMed
Regression of cirrhosis/advanced chronic liver disease (ACLD) after removal of the underlying cause of liver injury has been observed in human cirrhosis. However, detailed characterization of ACLD reg...
tiny.cc
December 19, 2024 at 11:44 AM
Identification of a lipid signature associated with regression of ACLD with taurocholic and taurochenodeoxycholic
acid emerging as key predictors. @docberza.bsky.social tiny.cc/jp12001
acid emerging as key predictors. @docberza.bsky.social tiny.cc/jp12001
We're launching our social media for the AClD league 2025 season! Stay tuned!
https://buff.ly/4aNU5Hz
https://buff.ly/4aNU5Hz
January 24, 2025 at 10:13 PM
We're launching our social media for the AClD league 2025 season! Stay tuned!
https://buff.ly/4aNU5Hz
https://buff.ly/4aNU5Hz
🚨 2 days to go‼️
✅ RCT challenges in ACLD
✅ Win ratio & ordinal outcomes
✅ Heterogeneity of Tx. effects
✅ Surrogate outcomes & Bayesian inference
✅ Methodological pitfalls in observ. studies
🔗 baveno8.org/presymposium/
🗓️ March 5
💰 Free for members | €100 non-members
✅ RCT challenges in ACLD
✅ Win ratio & ordinal outcomes
✅ Heterogeneity of Tx. effects
✅ Surrogate outcomes & Bayesian inference
✅ Methodological pitfalls in observ. studies
🔗 baveno8.org/presymposium/
🗓️ March 5
💰 Free for members | €100 non-members
March 3, 2025 at 8:09 AM
🚨 2 days to go‼️
✅ RCT challenges in ACLD
✅ Win ratio & ordinal outcomes
✅ Heterogeneity of Tx. effects
✅ Surrogate outcomes & Bayesian inference
✅ Methodological pitfalls in observ. studies
🔗 baveno8.org/presymposium/
🗓️ March 5
💰 Free for members | €100 non-members
✅ RCT challenges in ACLD
✅ Win ratio & ordinal outcomes
✅ Heterogeneity of Tx. effects
✅ Surrogate outcomes & Bayesian inference
✅ Methodological pitfalls in observ. studies
🔗 baveno8.org/presymposium/
🗓️ March 5
💰 Free for members | €100 non-members
🌟 NEW YEAR, NEW HORIZONS‼️
❓What are the current challenges in designing clinical trials in ACLD? How to measure success in cACLD, dACLD, and even recompensated cirrhosis?
🔗Registration at baveno8.org/presymposium/
🗓️March 5, 2025
💰Free for members | €100 non-members 👇
❓What are the current challenges in designing clinical trials in ACLD? How to measure success in cACLD, dACLD, and even recompensated cirrhosis?
🔗Registration at baveno8.org/presymposium/
🗓️March 5, 2025
💰Free for members | €100 non-members 👇
January 9, 2025 at 6:45 AM
🌟 NEW YEAR, NEW HORIZONS‼️
❓What are the current challenges in designing clinical trials in ACLD? How to measure success in cACLD, dACLD, and even recompensated cirrhosis?
🔗Registration at baveno8.org/presymposium/
🗓️March 5, 2025
💰Free for members | €100 non-members 👇
❓What are the current challenges in designing clinical trials in ACLD? How to measure success in cACLD, dACLD, and even recompensated cirrhosis?
🔗Registration at baveno8.org/presymposium/
🗓️March 5, 2025
💰Free for members | €100 non-members 👇
Genetik makas ve kök hücreler kullanarak Argininosüksinik asidüri (ACLD) adı verilen genetik bir karaciğer hastalığını tedavi etmişler.
www.eurekalert.org/news-release...
www.eurekalert.org/news-release...
April 5, 2024 at 2:49 PM
Genetik makas ve kök hücreler kullanarak Argininosüksinik asidüri (ACLD) adı verilen genetik bir karaciğer hastalığını tedavi etmişler.
www.eurekalert.org/news-release...
www.eurekalert.org/news-release...
another super banger from mop is the zandalari theme, whatever they putting in the mop water they need to bring it back, it almost has a mischievous chaotic touch to it in a way, very unique music for a very unique part of mop
www.youtube.com/watch?v=acLD...
www.youtube.com/watch?v=acLD...
Zandalari & Dinosaur Music - Mists Of Pandaria
YouTube video by Wowmusicable
www.youtube.com
February 18, 2025 at 7:28 PM
another super banger from mop is the zandalari theme, whatever they putting in the mop water they need to bring it back, it almost has a mischievous chaotic touch to it in a way, very unique music for a very unique part of mop
www.youtube.com/watch?v=acLD...
www.youtube.com/watch?v=acLD...
Alabama school leaders...
If you are looking for an ACLD-approved PLU, this one starts Feb. 1. (It's also approved for APLDS clock hours.)
All of the information is in this flyer: FrankBuck.org/pluflyer
If you are looking for an ACLD-approved PLU, this one starts Feb. 1. (It's also approved for APLDS clock hours.)
All of the information is in this flyer: FrankBuck.org/pluflyer
January 15, 2026 at 9:08 PM
Alabama school leaders...
If you are looking for an ACLD-approved PLU, this one starts Feb. 1. (It's also approved for APLDS clock hours.)
All of the information is in this flyer: FrankBuck.org/pluflyer
If you are looking for an ACLD-approved PLU, this one starts Feb. 1. (It's also approved for APLDS clock hours.)
All of the information is in this flyer: FrankBuck.org/pluflyer
Windsor Star 1980 Article on Kent Chapter Association of Learning Disabilities Members Meeting at Wheels Motor Inn #ChathamKent #WindsorEssex #Toronto #Ontario #Canada #Learning #Disability #Meeting #Conference #BellCanada #Sheraton #ACLD #Members #Association #Wheels #MotorInn
February 26, 2025 at 1:27 AM
Windsor Star 1980 Article on Kent Chapter Association of Learning Disabilities Members Meeting at Wheels Motor Inn #ChathamKent #WindsorEssex #Toronto #Ontario #Canada #Learning #Disability #Meeting #Conference #BellCanada #Sheraton #ACLD #Members #Association #Wheels #MotorInn